Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report.

Liu, Yanxin; Dong, Changjiang; He, Xucheng; Wu, Pan; Shu, Yamin; Chen, Li

Liu, Yanxin; Dong, Changjiang; He, Xucheng; Wu, Pan; Shu, Yamin; Chen, Li.

Affiliation

Liu Y; Department of Pharmacy, West China Second University Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
Dong C; Evidence-based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.
He X; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, China.
Wu P; Department of Pharmacy, Pengzhou People's Hospital, Pengzhou, China.
Shu Y; Department of Pharmacy, Pengzhou People's Hospital, Pengzhou, China.
Chen L; Department of Pharmacy, Pengzhou Second People's Hospital, Pengzhou, China.

BMC Nephrol ; 24(1): 51, 2023 03 10.

Article in En | MEDLINE | ID: mdl-36899322

Subject(s)

Lung Neoplasms; Uterine Cervical Neoplasms; Female; Humans; Aged; Middle Aged; Bevacizumab; Carboplatin/therapeutic use; Uterine Cervical Neoplasms/drug therapy; Uterine Cervical Neoplasms/etiology; Vascular Endothelial Growth Factor A; Hematuria/etiology; Endothelial Cells; Programmed Cell Death 1 Receptor; Paclitaxel/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Lung Neoplasms/drug therapy

Key words

Bevacizumab; Case report; Hematuria; Metastatic cervical cancer; Pembrolizumab

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Lung Neoplasms Type of study: Etiology_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: BMC Nephrol Journal subject: NEFROLOGIA Year: 2023 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google